vetbiolix.comCrawled Oct 15, 2026
Vetbiolix's clinical-stage pipeline includes VBX-2000 for osteoarthritis, VBX-1000 for periodontitis, and VBX-3000 for gut motility in dogs and cats.
The study achieved its primary objective, with significant reductions in plasma CTX1 and alveolar bone defect, and improvement in clinical measures of periodontal disease.
The VBX-2000 (piclidenoson; A3R agonist) proof-of-concept study in dogs with osteoarthritis achieved its primary objective and found a progressive, dose-dependent improvement in mobility score.
The VBX2400-CL-1001 proof-of-concept study found a statistically and clinically significant progressive improvement in mobility score after 90 days at 500 µg/kg twice daily.
Master degree – Clinical research 1y experience in multicentric Human and Veterinary clinical trials
The Vetbiolix team has expertise in drug development, veterinary clinical trials, and CMC.
ECVIM President Co-chair ACVIM Statement (2023) 30 international publications
Vetbiolix develops first-in-class treatments for Osteoarthritis, Periodontitis, and Gut Motility disorders in dogs and cats. Bridging human & veterinary innovation.
Vetbiolix specializes in veterinary biotechnology for companion animals.
Vetbiolix is a veterinary biotech developing first-in-class therapeutics for pets. Targeting Osteoarthritis, Periodontitis & Gut Motility in dogs and cats.
The privacy policy explains data processing, hosting, collection purposes, and retention under Regulation (EU) 2016/679 (GDPR).
Vetbiolix closes a €4 million Series A funding round and launches European regulatory clinical development of its first-in-class drug candidates. VBX-1000 and VBX-2000 are being developed to treat osteoarthritis and periodontitis in dogs and cats. The funding will support development of both candidates.
Dec 2024 · VetbiolixNews article
Vetbiolix reports final results from its proof-of-concept clinical study of VBX-2000 in dogs with osteoarthritis. The company says the study demonstrated positive efficacy signals; VBX-2000 is also known as piclidenoson.
Nov 2024 · VetbiolixNews article